|
2002
Meeting
|
Preliminary Program
CLINICAL AND NEUROBIOLOGICAL ASPECTS OF NEW VARIANT CJD
THE MINDS EAR
PERVASIVE DEVELOPMENTAL DISORDERS
held at
INSTITUTE OF CHILD HEALTH, London. Feb 21st and 22nd February 2002
CLICK HERE FOR A REGISTRATION FORM - WORD FORMAT or PDF
Thursday 21 February
09.30 - 10.20 Registration and coffee - Balcony
10.20 - 10.30 Welcome by Professor Michael Trimble, Chairman
Clinical and Neurobiological aspects of new variant CJD - Session
Chairman: Dr Simon Fleminger
10.30 - 11.15 Keynote address:
Variants of human prion disease: old and new
Professor John Collinge, Institute of Neurology/MRC Prion Unit, London
11.15 - 11.45 Neuropsychiatric aspects of new variant CJD
Professor Eve Johnstone, University of Edinburgh
11.45 - 12.15 New variant CJD: Clinical and Epidemiological Overview
Professor Rob Will, The National CJD Surveillance Unit, Edinburgh
Member's papers - Session Chairman: Dr Tim Griffiths
12.15 - 12.30 Distinct qualitative neuropsychological features in Creutzfeldt-Jakob
disease
Dr Julie Snowden, Greater Manchester Neuroscience Centre
12.30 - 12.45 Neural representation of voices "outside the head"
Dr Michael Hunter, University of Sheffield
12.45 - 13.00 Is auditory cortex used to process a signed language?
Dr Mairéad MacSweeney, Institute of Child Health
13.00 - 13.15 Auditory recognition memory in Schizophrenia using the remember/know
paradigm
Ms J Drakeford, The Queen Elizabeth Psychiatric Hospital, Birmingham
13.15 - 14.15 Lunch - Winter Garden
14.15 - 14.45 Annual General Meeting (members' only)
The Mind's Ear - Session Chairman: Dr Howard Ring
14.45 - 15.15 How does the brain process complex sound? Current controversies
Professor Robert Zatorre, Montreal Neurological Institute
15.15 - 15.45 The neural basis for auditory musical hallucinations
Dr Tim Griffiths, Newcastle University
15.45 - 16.15 Tea - Balcony
16.15 - 16.45 Update on auditory verbal hallucinations
Dr Philip McGuire, Institute of Psychiatry, London
16.45 - 17.15 Assessment and management of psychiatric disorders in deaf people
Dr Peter Hindley, St George's Hospital, London
17.15 Close of meeting
Friday 22 February
Pervasive Developmental Disorders - Session Chairman: Professor David
Skuse
09.15 - 10.15 Keynote address:
How the brain processes emotional and social stimuli
Dr Ralph Adolphs, University of Iowa
10.15 - 10.45 Is autism an extreme form of the male brain?
Dr Simon Baron-Cohen, Cambridge University
10.45 - 11.15 Autism and developmental receptive language disorder - a follow-up
comparison in early adult life. Social, behavioural, and psychiatric outcomes
Professor Patricia Howlin, St George's Medical School, London
11.15 - 11.35 Coffee - Balcony
Member's papers - Session Chairman: Dr Julie Snowden
11.35 - 11.50 Emotional memory in temporal lobectomy patients with unilateral
or bilateral damage
Dr Barbara Brierley, Kings College, London
11.50 - 12.05 Psychosis following temporal lobectomy
Dr Philip Shaw, Institute of Psychiatry
12.05 - 12.20 Rivastigmine is preferable to Olanzapine in the management of
dementia
with Lewy bodies (DLB)
Dr Giles Elrington, Oaks Hospital, Colchester
12.20 - 12.35 Magnetisation transfer detects anterior cingulate abnormalities
in Bipolar Disorder
Dr Stefania Bruno, Institute of Neurology
12.35 - 12.50 Near-Death Experiences in Children During Meningococccal Disease
Dr Dan Shears, Imperial College School of Medicine
12.50 - 13.05 A Neuropsychiatry Outreach Clinic
Dr Feargal Leonard, The Maudsley Hospital
13.05 - 14.15 Lunch - Winter Garden
New Drugs for Neuropsychiatry - Session Chairman: Professor Michael
Trimble
14.15 - 14.35 Deconstructing Serotonin
Professor Brian Leonard, National University of Ireland, Galway
14.35 - 14.55 Inhibiting Excitation and Exciting Inhibition
Professor John Jefferys, University of Birmingham
14.55 - 15.15 Neurotrophins in Alzheimer's Disease
Professor Gordon Wilcock, University of Bristol
15.15 - 15.35 Neuronal growth and synaptic plasticity: understanding antidepressant
action
Professor Ian Reid, University of Dundee
15.35 - 15.55 Beyond atypical drugs, the next generation of antipsychotics
Professor Rob Kerwin, Institute of Psychiatry
15.55 Tea - Balcony
Close of meeting